154 related articles for article (PubMed ID: 35353777)
1. Safety of Botulinum Toxin A Injections for Facial Rejuvenation: A Meta-Analysis of 9,669 Patients.
Gostimir M; Liou V; Yoon MK
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):13-25. PubMed ID: 35353777
[TBL] [Abstract][Full Text] [Related]
2. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
4. Safety of botulinum toxin type A: a systematic review and meta-analysis.
Naumann M; Jankovic J
Curr Med Res Opin; 2004 Jul; 20(7):981-90. PubMed ID: 15265242
[TBL] [Abstract][Full Text] [Related]
5. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
Dolar Bilge A; Sadigov F; Salar-Gomceli S
Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
[TBL] [Abstract][Full Text] [Related]
6. Facial aesthetics: is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials.
Gadhia K; Walmsley AD
Br Dent J; 2009 Sep; 207(5):E9; discussion 216-7. PubMed ID: 19749689
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. BTX-A Rejuvenation: Regional Botulinum Toxin-A Injection of the Platysma in Patients with Facial Sagging.
Zhou R; Fei Y; Sun L; Guo J; Zhou X; Zhang X
Aesthetic Plast Surg; 2019 Aug; 43(4):1044-1053. PubMed ID: 31093710
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A for facial wrinkles.
Camargo CP; Xia J; Costa CS; Gemperli R; Tatini MD; Bulsara MK; Riera R
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011301. PubMed ID: 34224576
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis.
Wu SJ; Xu YQ; Gao ZY; Wang ZP; Zhao F; Liu L; Wang S
Ren Fail; 2019 Nov; 41(1):937-945. PubMed ID: 31599184
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Qian H; Shao F; Lenahan C; Shao A; Li Y
Front Psychiatry; 2020; 11():603087. PubMed ID: 33343429
[No Abstract] [Full Text] [Related]
13. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Jan; 48(1):19-30. PubMed ID: 26560471
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Botulinum Toxin Injection on the Outcomes of Breast Surgeries: A Systematic Review and Meta-Analysis.
Awadeen A; Fareed M; Elameen AM
Aesthetic Plast Surg; 2023 Oct; 47(5):1771-1784. PubMed ID: 37464214
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.
Hary V; Schitter S; Martinez V
Eur J Pain; 2022 May; 26(5):980-990. PubMed ID: 35293078
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
Morra ME; Elgebaly A; Elmaraezy A; Khalil AM; Altibi AM; Vu TL; Mostafa MR; Huy NT; Hirayama K
J Headache Pain; 2016 Dec; 17(1):63. PubMed ID: 27377706
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Chen Y; Tsai CH; Bae TH; Huang CY; Chen C; Kang YN; Chiu WK
Aesthetic Plast Surg; 2023 Apr; 47(2):775-790. PubMed ID: 36694050
[TBL] [Abstract][Full Text] [Related]
20. Six years of experience using an advanced algorithm for botulinum toxin application.
Casabona G; Kaye K; Barreto Marchese P; Boggio R; Cotofana S
J Cosmet Dermatol; 2019 Feb; 18(1):21-35. PubMed ID: 30536548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]